生命科学资讯

Frontier, Harbour do licensing deals with GSK, Solstice

A federal experiment opens up a new market for digital health — if it works

Roche to stop work on bone health treatment for Duchenne

Merck reorganizes; Blackstone to fund trials for J&J drug

First test of gene therapy for rare form of autism is underway

Gilead to acquire cell therapy partner Arcellx for $7.8B

Novo Nordisk’s CagriSema beaten by Lilly’s Zepbound in head-to-head obesity trial

MoonLake has 'confidence' ahead of FDA submission, discloses mid-stage arthritis win

Potential Eylea competitor disappoints; FDA to review Moderna’s flu vaccine; Another rare disease rejection; and more

Vanda gets FDA approval for ‘franchise-extending’ antipsychotic

Grail's cancer test faces new uncertainty after UK study

Ionis scraps Alzheimer’s drug for people with Down syndrome

Supreme Court tariff ruling lets stand Trump’s authority to target pharma

Candel prices offering, signs royalty deal; Calquence label expands

Daiichi taps John Tsai to lead R&D as Ken Takeshita departs

Novartis to divest India unit to private equity-led consortium for $159M

Sanofi appoints specialty care head; Biogen chair to retire in June

Grail's cancer test misses primary study goal in UK study

AbbVie, PhRMA can proceed with 340B case in Hawaii

When a health tech startup gets stuck in regulatory limbo